Mega Genomics Limited (06667) Announces Monthly Share Capital Details
Bulletin Express
Mar 03
Mega Genomics Limited reported that as of 28 February 2026, total authorised share capital stood at USD 50,000, comprising 500.00 million authorised ordinary shares at a par value of USD 0.0001 each. The data showed that 224.30 million shares were issued, with no treasury shares, indicating no changes in issued share capital compared to the preceding month.
The disclosure also confirmed compliance with the mandatory public float requirement at the 25% threshold. No other share-related agreements or arrangements were reported during the month, and no changes were noted in warrants or convertible securities.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.